133 related articles for article (PubMed ID: 27196265)
1. Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.
Villanueva MA; August KJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1829-33. PubMed ID: 27196265
[TBL] [Abstract][Full Text] [Related]
2. Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia.
Huschart E; Ducore J; Chung J
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e880-e885. PubMed ID: 33625079
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Children Discharged Prior to Absolute Neutrophil Count Recovery After Admission for Febrile Neutropenia.
Peters S; Adler M; Rossoff J
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e948-e952. PubMed ID: 37700440
[TBL] [Abstract][Full Text] [Related]
4. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
Bash RO; Katz JA; Cash JV; Buchanan GR
Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
[TBL] [Abstract][Full Text] [Related]
5. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML).
Chow V; Dorcy KS; Sandhu R; Gardner K; Becker P; Pagel J; Hendrie P; Abkowitz J; Appelbaum F; Estey E
Leuk Res Rep; 2013; 2(1):26-8. PubMed ID: 24371771
[TBL] [Abstract][Full Text] [Related]
7. Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.
Campbell ME; Friedman DL; Dulek DE; Zhao Z; Huang Y; Esbenshade AJ
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115709
[TBL] [Abstract][Full Text] [Related]
8. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
9. Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia.
Aquino VM; Buchanan GR; Tkaczewski I; Mustafa MM
Med Pediatr Oncol; 1997 Mar; 28(3):191-5. PubMed ID: 9024515
[TBL] [Abstract][Full Text] [Related]
10. Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.
Alali M; Prather C; Danziger-Isakov LA; Kussin ML; Khalifeh M; Al Othman N; Bartlett AH
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e702-e709. PubMed ID: 37494607
[TBL] [Abstract][Full Text] [Related]
11. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient.
Mullen CA; Buchanan GR
J Clin Oncol; 1990 Dec; 8(12):1998-2004. PubMed ID: 2230891
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Readmission Following Febrile Neutropenia in Pediatric Oncology Patients.
McCormick M; Richardson T; Rapkin L; Kalpatthi R
J Pediatr Hematol Oncol; 2023 May; 45(4):e496-e501. PubMed ID: 36346651
[TBL] [Abstract][Full Text] [Related]
13. Management of chemotherapy-induced febrile neutropenia in pediatric oncology patients: A North American survey of pediatric hematology/oncology and pediatric infectious disease physicians.
Maxwell RR; Egan-Sherry D; Gill JB; Roth ME
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28748605
[TBL] [Abstract][Full Text] [Related]
14. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
Hodgson-Viden H; Grundy PE; Robinson JL
BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
[TBL] [Abstract][Full Text] [Related]
15. Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia. A preliminary prospective trial.
Cohen KJ; Leamer K; Odom L; Greffe B; Stork L
J Pediatr Hematol Oncol; 1995 Nov; 17(4):325-30. PubMed ID: 7583388
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for readmission after initial diagnosis in children with acute lymphoblastic leukemia.
Slone TL; Rai R; Ahmad N; Winick NJ
Pediatr Blood Cancer; 2008 Sep; 51(3):375-9. PubMed ID: 18393271
[TBL] [Abstract][Full Text] [Related]
17. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
Wananukul S; Nuchprayoon I; Siripanich H
J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
[TBL] [Abstract][Full Text] [Related]
18. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of guideline for treatment of febrile neutropenia in pediatric cancer at Siriraj Hospital.
Sanpakit K; Phuakpet K; Veerakul G; Narkbunnam N; Chokephaibulkit K
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S124-34. PubMed ID: 16858853
[TBL] [Abstract][Full Text] [Related]
20. Association Between Depth of Neutropenia and Clinical Outcomes in Febrile Pediatric Cancer and/or Patients Undergoing Hematopoietic Stem-cell Transplantation.
Alali M; David MZ; Danziger-Isakov LA; Bartlett AH; Petty LA; Schwartz T; Pisano J
Pediatr Infect Dis J; 2020 Jul; 39(7):628-633. PubMed ID: 32176187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
